NeuroPace Inc — Director's Dealing 2023

Feb 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2023-02-20

Reporting Person: Morrell Martha (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-20	Common Stock	A	80000	$0.00	Acquired	137164	Direct

Footnotes

F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 20, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter.